SwaLife Biotech
SwaLife Biotech finds plant molecules for cosmetics and creates anticancer alkaloids targeting DNA damage.
SwaLife Biotech finds plant molecules for cosmetics and creates anticancer alkaloids targeting DNA damage.
SwaLife Biotech is a biotechnology startup founded in 2017, headquartered in Ireland. The company's mission revolves around the discovery and synthesis of plant molecules for cosmetic and medical purposes. It has garnered attention for its work in developing next-generation therapies for cancer and chronic diseases. Leveraging advanced technologies including network pharmacology and AI, SwaLife Biotech has discovered five novel bioactive alkaloids from plants, which show promising results in inhibiting the DNA Damage Response (DDR) pathway, a crucial element in preventing drug resistance and cancer cell survival. The company's seed round investment in April 25, 2017, was led by investors SOSV and RebelBio. SwaLife Biotech's innovative approach not only targets cancer but also extends to managing chronic diseases, positioning it as a potential player in the realm of personalized treatments.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 2 |
|
25 Apr 2017 |
No recent news or press coverage available for SwaLife Biotech.
We care about your data, and we'd love to use cookies make your experience better.
